gary taubes glp 1 Episode 408: — unSILOed Podcast with Greg LaBlanc Diet or Drugs? | Gary

Dr Anastasiou explains: "In experiments in the lab, GLP-1-receptor agonists exerted powerful antioxidant effects which protected retinal cells against the type of damage that can occur in diabetes

Sixty-two percent of those adults took them to treat a chronic condition such as diabetes or heart disease, while the other 38 percent took them primarily to lose weight

Fu J, Nchambi KM, Wu H, Luo X, An X, Liu D

GLP-1 medications (not-FDA approved) are designed for long-term use and are not intended as a short-term solution

Conclusions A comprehensive strategy for obesity management using GLP-1 and GIP agonists must consider both metabolic and psychological factors

It can be chopped apart to form other molecules including GLP-1